Invictus MD Strategies EV/EBIT
Quel est le EV/EBIT de Invictus MD Strategies?
Le EV/EBIT de Invictus MD Strategies Corp. est N/A
Quelle est la définition de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT des entreprises dans Health Care secteur sur OTC par rapport à Invictus MD Strategies
Que fait Invictus MD Strategies?
Invictus MD Strategies Corp. invests in, acquires, and develops synergistic businesses in the cannabis industry in Canada. The company operates through two segments, Sale of Cannabis and Fertilizers. It produces and sells medical cannabis; and plant fertilizers, nutrients, and other supplies for hydroponics, as well as operates medical clinics in Alberta. The company was incorporated in 2014 and is headquartered in Vancouver, Canada.
Entreprises avec ev/ebit similaire à Invictus MD Strategies
- Gritstone Bio Inc a EV/EBIT de N/A
- Barnwell Industries a EV/EBIT de N/A
- Sweet Earth a EV/EBIT de N/A
- Qutoutiao Inc a EV/EBIT de N/A
- ManifestSeven a EV/EBIT de N/A
- Avidian Gold a EV/EBIT de N/A
- Invictus MD Strategies a EV/EBIT de N/A
- ObsEva SA a EV/EBIT de N/A
- Pharnext SA a EV/EBIT de N/A
- TransAtlantic Petroleum Ltd a EV/EBIT de N/A
- Q-Gold Resources a EV/EBIT de N/A
- Marinus Pharmaceuticals Inc a EV/EBIT de N/A
- Jaguar Health Inc a EV/EBIT de N/A